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Abstract 
In this paper, a microfluidic silicon chip with poly(ethylene glycol) (PEG) 
hydrogel microarray on the nanoporous anodized aluminum oxide (AAO) membrane 
was fabricated to form cell based microarray with controlled drug delivery. The PEG 
hydrogel microstructures were fabricated using photolithography on nanoporous 
alumina surface modified with a 3-(Trimethoxysilyl)propyl methacrylate (TPM) 
monolayer. During the photopolymerization reaction, 10x10 hydrogel microwell 
arrays were covalently bonded to the substrate via the TPM monolayer for cell 
patterning. Human KYSE-30 esophageal squamous epithelial cancer cells were shown 
to selectively adhere on the TPM modified alumina surface inside the microwells. The 
diffusion studies for the anti-cancer drug molecule of cisplatin were carried out for the 
microfabricated membrane array using a mini-diffusion chamber.  The diffusion 
curves for the pore size of 25 nm and 55 nm showed different release profiles. Then, 
the drug testing experiment with cisplatin was explored using the microfabricated 
membrane array with the pore size of 55 nm for testing the drug effects on the 
KYSE-30 cancer cells. The cytotoxic effects of cisplatin on cancer cell number and 
cell morphology within microwells were explored based on this cell microarray.  
Key words: Nanoporous alumina membrane; Drug release; Cisplatin; Poly(ethylene 
glycol) (PEG); Cell based microarray 
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1 Introduction 
Cells usually integrate and respond to the surrounding environment such as 
chemicals and biomolecules in the fluids, physical properties (i.e. mechanical 
properties) of the substrates, and interactions between neighboring cells [1-2]. The 
ability to engineer cell-surface interactions for cell patterning and control sampling of 
analytes is important to study the effects of the microenvironment on cellular behavior 
[2-3].  
Inorganic nanoporous alumina membrane, fabricated by electrochemical 
anodization technique, is a kind of material with self-ordered nanopores [4]. The 
nanopores diameter and length can be precisely controlled by the established 
fabrication process [5-9]. Due to its well-defined pore size and high pore density, 
nanoporous alumina membrane has been used for a wide of applications such as 
nanomaterial preparation [10], solution control regulation [11], DNA filtering and 
detection [12-14]. Recently, the controlled drug molecule release using alumina 
membrane was also explored for potential immunoisolation application [15]. 
Furthermore, due to its good biocompatibility, alumina membrane has already been 
used as a good substrate for cell culture [16] and tissue constructs [17]. These features 
make the nanoporous alumina membrane to have excellent potential for drug 
sampling devices in cellular behavior study. However, there are few examples to 
explore the possibility of generating cell based microarray on nanoporous alumina 
membrane which can be a potential in vitro analysis system for cell drug interaction 
due to the well defined diffusion transport effects of nanopores.  
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In this study, nanoporous alumina membrane was integrated with hydrophilic 
poly(ethylene glycol) (PEG) hydrogel layer by photolithography for the controlled 
delivery of specific anti-cancer drug cisplatin to the adherent cancer cells on the 
alumina membrane. In order to make PEG hydrogel attach on the nanoporous 
membrane, the alumina substrate was first grafted with a silane monolayer, which 
could covalently bond with PEG hydrogel during photo-polymerization process. The 
hydrophobic silane monolayer could also improve protein and cell attachment on the 
alumina surface which was not covered by PEG layer. Thus, cancer cell microarrays 
could be formed on the cell adhesive nanoporous alumina membrane surrounded with 
cell repelling hydrogel regions. A mini diffusion chamber with two compartments 
separated by the microfabricated membrane array was used for the diffusion 
experiments with the model anti-cancer drug cisplatin. During the drug testing 
experiments for KYSE-30 cancer cells, the concentration of cisplatin on the 
compartment with adherent cancer cells was controlled by the diffusion through the 
membrane. Adherent cancer cell number within the microwells and cell morphology 
change under the diffusion of cisplatin was also monitored.  
 
2. Materials and Methods 
2.1 Materials 
Acetone, oxalic acid, chromic acid, phosphoric acid, 3-(Trimethoxysilyl)propyl 
methacrylate (TPM), poly(ethylene glycol) diacrylate (PEGDA, average Mn=700), 
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toluene, methanol, hydrogen peroxide were obtained from Sigma-Aldrich (St. Louis, 
USA). Irgacure 2959 was provided by Ciba Specialty Chemicals Inc (USA). 
Fibronectin and Bovine serum albumin (BSA) was purchased from Roche Inc 
(Germany).  
 
2.2 Fabrication of nanoporous alumina membrane on silicon substrate 
The fabrication of nanoporous alumina membrane on a silicon substrate was 
based on the anisotropic silicon etching and the two-step anodization of deposited 
aluminum thin film [8-9]. The whole process is shown in Fig. 1. 
For the first step of fabrication of silicon microfluidic structure, a pre-cleaned 4 
inch silicon (Si) wafer with a low stress silicon nitride layer on both sides was used as 
the starting substrate. First, Si3N4 on the back side was patterned using 
photolithography following by reactive ion etching (RIE) to open windows for 
microwells. Then, 30% potassium hydroxide (KOH) solution was used as the wet 
etchant to etch through the back side of the Si substrate at 80oC until it reaches the 
etch-stop Si3N4 layer. KOH preferentially etches <100> crystal plane, resulting in a 
“V-groove” with the inward slope angle of 54.70.  
Then, a thin layer of aluminum (Al) of 1000 nm was deposited onto the front side 
of the Si substrate by magnetron sputtering (90w, power density 3.8w/cm-2) using a 
99.999% Al target in the atmosphere of research-grade Ar at 4x10-4 Torr.  The 
deposition rate was 1 nm/s.  The samples were mounted on a rotating stage to ensure 
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an even coating of the Al layer. The aluminum layer was then anodized following the 
standard two-step anodization procedures to form nanoporous membrane. The first 
anodization process was performed at 5oC for 10 min under DC voltage (50V) in 0.3 
M oxalic acid. The aluminum layer on the front side of the substrate was used as 
anode while Pt sheet was used as cathode. The solution was stirred in order to 
accelerate the dispensation of the generated heat. Then, the substrate was rinsed with 
distilled (DI) water and immersed into 4 wt% chromic acid and 8 wt% phosphoric 
acid in the etching step for 5 minutes. The second anodization step was then repeated 
at 50V for 8 min in 0.3 M oxalic acid solution at 5oC. After the second anodization, 
the silicon nitride membrane support was removed by RIE etching. Alumina barrier 
layer removal and pore widening were followed in 8 wt% phosphoric acid for 5 to 20 
minutes at room temperature dependent of the desired pore size. It was important to 
keep the silicon nitride membrane support before the anodization which could 
obviously keep the aluminum and alumina film intact before and after anodization.  
If silicon nitride support membrane on the backside was removed before anodization, 
the alumina layer was easy to break or detach from the substrate during anodizaiotn 
process and the successful rate was much lower.    
 
2.3 Silane modification of the nanoporous alumina surface 
Recently, silane treatment has been used for surface modification of alumina 
[18-20]. The fabricated nanoporous alumina membranes were boiled in 30% 
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hydrogen peroxide for 30 min to clean the surface. This step introduced OH groups on 
the nanoporous alumina surface which facilitated subsequent silane modification by 
TPM. For the formation of TPM monolayer, the nanoporous alumina surfaces were 
immersed into a 5% (V/V) solution of TPM in anhydrous toluene at 500C for 24 h. 
Then the alumina surfaces were washed by toluene followed by methanol and 
deionized water. The alumina surfaces were further air dried.   
 
2.4 Fabrication of PEG hydrogel microstructures on AAO surface 
PEG hydrogel microstructures were fabricated with PEG-DA by 
photopolymerization. In this experiment, a SU-8 chamber was first fabricated on the 
alumina surface of the chip. A 50 μm SU-8 2050 photoresist layer was coated on the 
alumina surface with the speed of 3000 rpm for 90s using a spin coater. Then the 
SU-8 layer was pre-baked at 65oC for 3min and 95oC for 9 min to evaporate the 
solvent. The sample was then UV exposed using a photomask with a square pattern at 
10mW/cm2 for 70s. Post exposure was carried out at 65oC for 1 min and 95oC for 7 
min.  The substrate was then developed in PGMEA (propylene glycol monomethyl 
ether acetate) from Microchem for 20 min, washed with isopropyl alcohol, and dried 
with a nitrogen gun. After developing, the unexposed center area was removed from 
the alumina surface and the SU-8 chamber was built.  
Then, the PEG gel precursor was prepared by dissolving 20 mg Irgacure 2959 
(photo-initiator) in 15 mL of PEG-DA solution. Thes precursor solution with 1.5 ml 
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was then injected into the pre-fabricated SU-8 chamber. A glass slide was used to 
cover the chamber and a photomask with the desired pattern was put onto proximity 
of the gel precursor. The solution was then exposed to UV light with the energy of 
30mW/cm2 for 90s using a 365 nm, UV spot curing system (EXFO, S1000 Omnicure, 
Canada). The exposed regions became insoluble and the desired microstructures were 
achieved by washing away the unreacted regions with DI water. The exposure energy 
and exposure time should be optimized to make sure that no PEG remained inside the 
microholes. The cross linking of PEG layer on alumina surface was achieved by the 
covalent coupling method [21-23]. The surface tethered methacrylate groups created 
by silane modification were capable of covalent bonding with PEG-DA during the 
free radical induced photoreaction (Fig. 2). Immersing hydroxylated alumina surfaces 
into TPM silane solution formed a dense network of Al-O-Si bonds on the substrates. 
This silanization process generated the methacrylate reactive groups on the substrate 
for further graft polymerization. When PEG-DA was exposed to UV light in presence 
of photoinitiator, acrylate groups formed free radical sites which reacted with TPM 
silane.  
 
2.5 Surface characterization 
The formation of TPM layer on nanoporous alumina surface was characterized by 
water contact angle measurement. The static contact angles of water droplets were 
measured by the sessile drop method using a contact angle goniometer (Rame-hart 
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model 250-F1 standard goniometer, rame-hart instrument co., USA) [24-25]. The 
samples were placed in a vacuum oven overnight to thoroughly remove water content 
of alumina before measurement. A water droplet was placed in the center of the 
membrane surfaces during the measurement. Contact angles on both sides of the 
water droplet were measured and averaged. The values reported are averages of ten 
measurements made on different areas of each specimen at room temperature. 
Protein adsorption experiments were explored to future analyze the surface 
modification effects. Rhodamine-labelled fibronectin or bovine serum albumin (BSA) 
was dissolved in phosphate-buffered saline (PBS) (Sigma) at 50μg/ml. The substrates 
were washed by PBS and then immersed in the rhodamine-labelled fibronectin or 
BSA solution for 2 h at room temperature. After being washed three times with PBS 
buffer and rinsed with DI water, the samples were observed with a fluorescence 
microscope (Nikon 80i fluorescence microscope, Nikon, Japan).  
The pore structures of nanoporous alumina samples were observed by 
scanning electron microscopy (SEM). The alumina samples were sputtered with a 10 
nm gold layer. Then, the samples were imaged in the SEM at a voltage of 20 kV with 
various magnifications (JEOL, JSM-63335F, Japan). 
 
2.6 Cisplatin release measurement  
The diffusion studies for the anti-cancer drug molecule of cisplatin (300.1 Da) 
were carried out using a mini-diffusion chamber. A mini-diffusion chamber was 
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designed and fabricated using Teflon. The chamber consists of A and B compartments 
with fixed volume of 10 ml. The microfabricated membrane array was placed 
between the two compartments and screwed together (Fig. 3). Compartment A was 
filled with 50 μM cisplatin dissolved in PBS buffer and compartment B was filled 
with PBS buffer only. The donor compartment A is filled with solution of interest and 
the recipient compartment is filled with PBS buffer only. 100 μl samples were taken 
from the recipient chamber at the regular time intervals for absorbance measurement. 
After each sampling, the recipient compartment volume was restored to 10 ml by 
adding 100 μl PBS buffer. Cisplatin concentration was determined by means of 
ultraviolet spectroscopy (Hewlett Packard 8453 UV–VIS spectrophotometer). The 
measurements of each sample were repeated 5 times. Intensities of the maximum 
absorbance of cisplatin (λ = 301 nm) were converted to the corresponding 
concentration by calibration. The concentration in compartment A is treated as an 
infinite source ∞C . Release volume is expressed as ∞CC / with the change of time for 
normalized membrane area.  
 
2.7 Cancer cell culture and morphology 
Human KYSE-30 esophageal squamous epithelial cancer cell line was obtained 
from American Type of Culture Collection (ATCC).  KYSE-30 cells were 
maintained routinely in Dulbecco's Modified Eagle Medium (DMEM) with 
4,500mg/L glucose (Invitrogen) as basic medium supplemented with 5% Fetal Bovine 
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Serum (FBS, Invitrogen) together with penicillin and streptomycin (Invitrogen). They 
were cultured on a 35mm diameter tissue culture dish (Nunc GmbH & Co. KG, 
Germany) in a humidified incubator at 37oC with 5% CO2/ 95% air. The culture 
medium was exchanged three times per week and routine subculturing of confluent 
cell layer was performed using standard trypsinization (0.05% (w/v)/ 1.5 mM EDTA) 
techniques. The cells were seeded on patterned alumina surfaces treated with 
fibronectin and cultured in the incubator. Phalloidin (Invitrogen) and propidium 
iodide (Invitrogen) were used to stain cytoskeletal stress fibers structure and nuclei of 
cells respectively.  
KYSE-30 cancer cell morphology after adhesion was further examined using 
SEM. The cells were first fixed on the alumina membranes in 3% glutaraldehyde in 
0.1M phosphate buffer for 2 h and dehydrated in a graded series of ethanol (35%, 
50%, 70%, 95% and 100%) for 10 min each and then air dried for 24h. Then, the 
samples were sputtered with a gold layer of 10 nm and observed at a voltage of 20V 
using a JEOL, JSM-63335Fc SEM.  
 
3 Results and Discussion  
3.1 Fabricated chip with nanoporous alumina membrane   
The microchip with nanoporous alumina membrane was successfully fabricated 
following the steps described in Methods. The average nanopore size diameter is 
around 25 nm and 55 nm. In the study, 3-(Trimethoxysilyl)propyl methacrylate (TPM) 
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was used to modify nanoporous alumina membrane to form a hydrophobic monolayer 
on the surface as described with details in Methods. The TPM monolayer could help 
PEG hydrogel attach to the alumina surface through the reaction of acrylate groups. 
The fabricated PEG microstructures were firmly anchored to the alumina surface by 
TPM monolayers. The reaction process is shown in Fig.2.  
 
3.2 Fabrication of PEG hydrogel microstructures on nanoporous alumina membrane 
A photomask of a 10x10 array with a diameter of 500 μm was used to fabricate 
the PEG hydrogel negative patterns by UV initiated polymerization. Hydrogel 
microstructures were successfully fabricated on the TPM self-assembled nanoporous 
alumina membrane (Fig. 4a). Each microwell was surrounded by PEG hydrogel and 
the height of microwell was approximately 15 μm which was controlled by the 
pre-fabricated SU-8 chamber (Fig. 4b). The unreacted PEG macromer was washed 
away by DI water and the clear spatial distribution of hydrophilic PEG and 
hydrophobic nanoporous alumina membrane was created. The PEG microstructures 
were anchored by TPM monolayer on the alumina membrane which was more stable 
than the physical adsorption method. The image of fluorescence-labeled BSA 
adsorption circle pattern was also shown in Fig. 4c which was achieved by the 
different protein adsorption capabilities between PEG and silane modified nanoporous 
alumina membrane. For the drug release purpose, the nanopores of the membrane 
should be open, and thus clogging of the pores by PEG during the fabrication was 
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explored. Based on the SEM images after the silane modification and PEG 
photopolymerization (Fig. 4d), the “open” pores were exposed to outside and the 
fabrication process didn’t change the nanopore structure of the membrane. Clear 3-D 
hydrogel microwells with non-clogged pores on the bottom nanoporous alumina 
membranes were observed. 
 
3.3 Protein adsorption analysis and water contact angle measurement  
Surface modification was essential for the fabrication of hydrogel microwells 
with good adhesion on nanoporous alumina surface.  To visualize the spatial surface 
modification effects, the water contact angle measurements and the interaction of 
modified membranes with fluorescence-labeled fibronectin were explored 
respectively.  
The surface modification of nanoporous alumina membranes is characterized by 
water contact angle measurement. The water contact angels of unmodified 
nanoporous alumina membrane, PEG hydrogel, and silane modified nanoporous 
alumina membrane are measured. In Fig. 5, the unmodified nanoporous alumina 
membrane is hydrophilic with the water contact angle close to zero. The water contact 
angle of PEG surface is around 22o. The silane-modified nanoporous alumina surface 
has the largest angle which is more than 130°.  For protein adsorption experiment, 
the fluorescence-labeled fibronectin adsorption on silane modified nanoporous 
alumina surface is set as 100%.  Unmodified nanoporous alumina surface and PEG 
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surface have much lower fibronectin adsorption compared with silane modified 
nanoporous alumina surface, which are around 18% and 28%, respectively (Fig. 5).  
The big difference in fibronectin adsorption is observed between PEG and TPM 
silane modified nanoporous alumina surfaces. So if Extracellular Matrix (ECM) 
protein such as fibronectin is deposited on the microfabricated PEG-nanoporous 
membrane array, the difference in ECM protein adsorption between the PEG hydrogel 
surface and the silane modified alumina surface inside the microwell can result in cell 
attachment. Cells will mostly adhere on the surface inside the microwell which is 
discussed in next section.   
 
3.4 Cell patterning    
The PEG hydrogel micropatterns on the silane modified nanoporous alumina 
membrane caused hydrophobic or hydrophilic patches on the chip, which would 
attract or repel cells. The substrates with patterned PEG microwells were first treated 
with fibronectin and then incubated with KYSE-30 cancer cells.  After one day 
incubation with cells, the alumina membrane was removed from cell culture media 
and then briefly washed with PBS buffer. Finally, the cells were stained and observed 
using a fluorescence microscopy. Fig. 6a and 6b show the fluorescent images before 
and after cancer cells seeding and incubation after 1 day. The difference of cell 
adhesion between PEG hydrogel and TPM modified nanoporous alumina surface 
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enabled the spatial control of cells patterning. Fig. 6c shows the SEM image of 
adherent KYSE-30 cancer cell on the nanoporous alumina surface.  
 
3.5 Cisplatin diffusion  
The diffusion studies for the anti-cancer drug molecule of cisplatin were carried 
out for the microfabricated membrane array using a mini-diffusion chamber. 
Compared with 25 nm and 55 nm nanopore, cisplatin is a small molecule with the 
molecular diameter under 1 nm.  The Fick’s diffusion behavior should be observed 
for cisplatin diffusion, i.e., the geometry of the nanopore size does not constrain the 
diffusion of the molecules. The process of one species across a membrane in the 
diffusion chamber with two compartments A and B could be described by the Fick’s 
first law of diffusion:  
L
CCADJ BAeffeff
−=               (1) 
Where, J is the molar flux, effD  is the effective diffusion coefficient, effA  is the 
cross section pore area, L is the membrane thickness, and C is the concentration in 
the compartments .  
In this experiment, there is no big difference for the diffusion coefficient of 
cisplatin Deff for the two kinds of nanoporous membranes since the relatively large 
pore will not limit the diffusion of small cisplatin molecules.   However, in the 
fabrication process of this paper, the pore cross section area effA  is proportional to 
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the square of the pore size 2d , thus effA  increases with the square of the pore size
2d . 
If the other conditions are the same, the diffusion rate of the cisplatin for the 
nanoporous membrane of 55nm is much larger than that of nanoporous membrane 
with the size of 25 nm.  Fig. 7 shows the cisplatin diffusion curve through 
nanoporous alumina membrane with pore size 25 nm and 55 nm.  At the initial stage 
of diffusion, the release volume increases linearly with time, where the slope of the 
curve is the diffusion rate J. The diffusion rates for both 25 nm and 55nm don’t 
change much due to the stable concentration difference according to the Fick’s 
diffusion model in Eq. 1. The slope of 55 nm is 4 to 5 times of that of 25 nm. Then, 
with the lapse of diffusion time, it is observed that the slope of curve (i.e. the 
diffusion rate) for 55 nm become smaller after 40 minutes and the slope for 25 nm 
almost keeps unchanged for the whole release curve (Fig. 7).  It can be explained 
that the concentration difference (CA-CB) for larger pore size of 55 nm decreases 
faster than that of 25 nm. The experiment results in Fig. 7 agree quite well with the 
diffusion model based on Fick’s first law.  Generally, larger pore size of 55nm has 
faster drug release curve of cisplatin. Using larger pore size of 55 nm, complete 
release of small molecules of cisplatin could be achieved within a few hours.  
 
3.6 Cell based microarray for anti-cancer drug effects study  
In this experiment, the well established anti-cancer drug of cisplatin was used to 
explore the effects on KYSE-30 cancer cells using the microfabricated membrane 
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array with the pore size of 55 nm. The cells were first seeded on the patterned alumina 
surface treated with fibronectin and cultured in the incubator for 3 days. Then, soft 
washing was followed by PBS solution. The diffusion chamber was established as 
described in Section 3.5 using the microfabricated membrane array with adherent 
cancer cells.  Then, the cisplatin drug was added to the chamber without cells at a 
concentration of 50 μM.  Due to the concentration difference between the two 
compartments, the drug molecules were diffused through the nanopores and interacted 
with the adherent cancer cells on the nanoporous membrane. The cancer cells were 
exposed to the cisplatin diffused through the nanoporous membrane from 15 minutes 
to 7 hours and then cultivated in fresh medium without drug in incubator for 12 hours. 
At the end of each incubation experiment, the cells were stained and counted under a 
fluorescence microscope.   
With respect to cisplatin release through the nanoporous membrane, the drug was 
extracted from the medium of the cell exposure chamber at different time and 
quantified by an UV–VIS spectrophotometer. The controlled drug released profile 
was achieved and the drug concentration reached a plateau within 7 hours (Fig. 8). 
Compared with the cisplatin diffusion curve without cells shown in Fig. 7, the drug 
release rate was apparently lower in the first two hours due to the partial covering of 
the nanopores by the adherent cells. We also explored the cytotoxic effect of cisplatin 
on the KYSE-30 cancer cells with 12h culture in normal medium after the cells were 
exposed to cisplatin released through the nanopores at different time points. A clear 
anti-proliferation effect was observed in Fig. 8, where the adherent cancer cell number 
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per microwell decreased with the drug release time due to increased cisplatin 
concentration.    
The cellular morphology changes during the cisplatin diffusion were studied by 
fluorescence microscopy. Cellular morphology is one of the most important 
parameters in anti-cancer drug chemotherapeutics. The cytoskeleton consists of a 
complex network of filamentous proteins which are involved in regulation of cell 
morphology and adhesion. Most anti-cancer agents which target cytoskeleton such as 
cisplatin, modulate the cell morphology by interacting with the microfilaments [26]. 
Cisplatin inhibits cancer cell-substrate adhesion and also induces cell morphological 
changes such as cell rounding [27-30].  Fig. 9a shows the fluorescence image of 
stained KYSE-30 cancer cells immobilized on the PEG-alumina based micro-array 
chip. It could be observed that the cell spreading was confined within the microwells. 
The fluorescence image stained for nuclei was also shown in Fig. 9b where the cell 
number within each microwell could be counted.  Fig. 9c shows the enlarged 
fluorescence image stained for stress fibers of cytoskeleton structure. In the absence 
of cisplatin, the cells anchored well to the surface and showed good cell spreading 
with prominent stress fibers within each microwell. Cell detachment and morphology 
after cisplatin treatment could also be examined by the fluorescence microscopy.  
Fig. 9d and 9e shows the microwell array with KYSE-30 cancer cells at 7 h exposure 
to cisplatin diffused through nanoporous membrane (C∞=50μM).  A marked cell 
detachment was observed after cisplatin exposure.  The detached cells left the 
growth surface due to the loss of cell-substrate contacts. A series of characteristics 
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including loss of cell volume, reconstructing of actin fibers, shrinkage of cell 
spreading area and even round-up of cells were observed in the enlarged fluorescence 
image (Fig. 9f).  
 
4. Conclusion 
The present paper outlines a microfludic system with PEG hydrogel micro-arrays 
on nanoporous alumina membrane on a silicon chip for cell drug interaction analysis.  
The PEG hydrogel microwells were fabricated on the silane modified nanoporous 
alumina surface with controlled spatial distribution of hydrophobic and hydrophilic 
regions. ECM proteins were selectively deposited on the nanoporous membrane 
within PEG microwells. KYSE-30 cancer cells were then successfully patterned 
within the microwells to form cell microarrays. For demonstration, anti-cancer drug 
cisplatin was used as a model drug for diffusion experiments to explore the effect on 
cancer cell adhesion and morphology. The nanoporous membranes acted as a cell 
interface for culturing and modulated the cell environment by well controlled drug 
delivery. The integration of nanoporous alumina membranes on a microfabricated 
silicon chip avoided the brittleness of pure alumina membrane and allowed 
integration other functions for further development.    
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Fig. 1 Process flow for the fabrication of PEG hydrogel microarrays on nanoporous 
alumina membrane based on a silicon substrate.  
Fig. 2 Schematic view of the silanization and PEG grafting process on nanoporous 
alumina surface.  
Fig. 3 Mini-diffusion chamber setup used to test the microfabricated membrane array. 
Fig. 4 (a) The 10x10 microwells array on the modified nanoporous membrane; (b) 
Scanning electron microscopy image of 3-D hydrogel microwells with nanoporous 
membrane in the bottom; (c) Fluorescent BSA adsorption micro-patterns; (d) “Open” 
nanopores were observed in the microwells.    
Fig. 5 Water contact angle and fluorescence labeled fibronectin adsorption 
measurements on three kinds of substrates: unmodified nanoporous alumina surface 
(contact angle: 6±0.4o, protein adsorption: 18%), PEG hydrogel surface (contact angle: 
22±1.6o, protein adsorption: 28%) and TPM silane modified nanoporous alumina 
surface (contact angle: 132±7.2o, protein adsorption: 28%). For fibronectin adsorption 
measurement, the intensities were normalized using that of the silane modified 
nanoporous alumina surface (100%).  
Fig. 6 (a) Fluorescence image of cancer cell patterning before and (b) after cancer 
cells seeding for one day, (c) SEM image of adherent KYSE-30 cancer cell on the 
nanoporous alumina surface.  
 25
Fig. 7 Normalized release curve of cisplatin diffused through the microfabricated 
membrane array with the pore size of 25 nm and 55 nm.  
Fig. 8 Controlled release curve of cisplatin through the microfabricated membrane 
array with cultured KYSE-30 cancer cells and cytotoxicity of cisplatin referred to the 
adherent cell number change within microwells (n=5). The nanopore size of the tested 
membrane array is 55 nm.  
Fig. 9 Fluorescence images for cell based microarray before and after addition of 
cisplatin. (a) Cellular microarray with phalloidin staining for microfilament, (b) 
cellular microarray with propidium iodide staining for nuclei, and (c) enlarged 
fluorescence image stained for stress fibers of cytoskeleton structure after KYES30 
cancer cells cultured on the microfabricated membrane array after 3 days incubation; 
(d) Cellular microarray with phalloidin staining for microfilament, (e) propidium 
iodide staining for nuclei, and (f) enlarged fluorescence image stained for stress fibers 
of cytoskeleton structure after KYSE-30 cancer cells at 7h exposure to cisplatin 
diffused through nanoporous alumina membrane (C∞=50μM).  
 
 
 
 
 
 26
Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. Anodization for Al2O3 nano-membrane1. Silicon substrate with Si3N4
3. KOH etching to get micro-well arrays
4. Deposit Al thin film
2. Si3N4 RIE etching to open windows
7. Surface modification and PEG microwells
fabrication
AlSi3N4 Si
PEGAl2O3
Modified 
Al2O3
6. Si3N4 RIE etching and the barrier layer 
removal
 27
Figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cleaned by
Hydrogen peroxide
OH
Toluene, 60oC , 24 h
AAO-OH
TPM PEGDA
O
H3CO Si
O
O
H3C
OCH3
C
AAO
AAO-TPM
UV + initiator O
H3CO Si
O
O
H3C
OCH3
C O
n
AAO-TPM-PEG
O
 28
Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Microfabricated
membrane arrayScrew
Compartment A Compartment B
Sampling portInjection port
 29
Figure 4 
 
 
 
 
 
 
 
 
 30
Figure 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
20
40
60
80
100
120
140
100
80
60
40
20
0
Unmodified 
nanoporous alumina
PEG Modified nanoporous alumina
C
on
ta
ct
 a
ng
le
%
 a
ds
or
pt
io
n 
re
la
tiv
e 
to
 m
od
ifi
ed
 A
A
O
Water contact angle
Fibronectin adsorption
C
on
ta
ct
 a
ng
le
%
 a
ds
or
pt
io
n 
re
la
tiv
e 
to
 m
od
ifi
ed
 A
A
O
 31
Figure 6 
 
 
 
      
 32
Figure 7 
0 50 100 150 2000
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
C
on
ce
nt
ra
tio
n 
(C
/C
∞
)
Time (minutes)
55 nm
25 nm
C
on
ce
nt
ra
tio
n 
(C
/C
∞
)
 
 
 
 
 
 
 
 
 
 33
Figure 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C
el
l N
um
be
r 
(p
er
 m
ic
ro
w
el
l) Drug C
oncentration (μ
M
)
Time (minutes)
0
10
20
30
40
50
60
70
80
90
0 50 100 150 200 250 300 350 400 450
0
10
20
30
40
50
60
Drug concentration
Cell number 
C
el
l N
um
be
r 
(p
er
 m
ic
ro
w
el
l) Drug C
oncentration (μ
M
)
C
el
l N
um
be
r 
(p
er
 m
ic
ro
w
el
l) Drug C
oncentration (μ
M
)
 34
Figure 9 
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